Abcam, ab216470, MLN-4924, NEDD8-activating enzyme inhibitor

Size: 200µg / 1mg
MW 443.5 Da, Purity >98%. Potent NEDD8-activating enzyme (NAE) inhibitor (IC 50 = 4.7 nM). Selective relative to the closely related activating enzymes ubiquitin-​activating enzyme (UAE) and SUMO-​activating enzyme (SAE). Adenosine 5'-​monophosphate analog. Disrupts cullin-RING ligase (CRL)-mediated protein turnover leading to apoptosis in human tumour cells by deregulating S-phase DNA synthesis.
Key facts
CAS number:905579-51-3,
Purity:>98%,
Form:SolidSee storage information,
Molecular weight:443.5 Da,
Molecular formula:C21H25N5O4S,
PubChem:16720766,
Nature:Synthetic,
Solubility:Soluble in DMSO to 20 mM,
Biochemical name:Pevonedistat,
Biological description:Potent NEDD8-activating enzyme (NAE) inhibitor (IC50 = 4.7 nM). Selective relative to the closely related activating enzymes ubiquitin-​activating enzyme (UAE) and SUMO-​activating enzyme (SAE). Adenosine 5'-​monophosphate analog. Disrupts cullin-RING ligase (CRL)-mediated protein turnover leading to apoptosis in human tumour cells by deregulating S-phase DNA synthesis.,
Canonical smiles:C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,
Isomeric smiles:C1CC2=CC=CC=C2[C@H]1NC3=C4C=CN(C4=NC=N3)[C@@H]5C[C@H]([C@H](C5)O)COS(=O)(=O)N,
InChi:InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1,
InChiKey:MPUQHZXIXSTTDU-QXGSTGNESA-N,
IUPAC Name:[(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate

Properties and Storage Information:
Shipped at conditions-Ambient - Can Ship with Ice, Appropriate short-term storage conditions--20°C, Appropriate long-term storage conditions--20°C, Storage information-Store under desiccating conditions

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
The NEDD8 UBA3 protein complex plays a fundamental role in the process of neddylation where NEDD8 (Neural precursor cell expressed developmentally down-regulated 8) conjugates to target proteins. UBA3 is the catalytic subunit of the E1 enzyme involved in this pathway. This complex is expressed ubiquitously in various tissues. Its molecular weight is approximately 25 kDa for NEDD8 and about 57 kDa for UBA3. An essential aspect of NEDD8 UBA3 function is the modulation of protein stability and activity through NEDD8 conjugation which shares a high degree of similarity with ubiquitination but is distinct in its specific targets and outcomes.
Biological function summary
The NEDD8 UBA3 complex is indispensable for the activation of cullin-RING E3 ubiquitin ligases (CRLs) which regulate protein degradation. As a part of the neddylation pathway this complex modifies cullin proteins enhancing their ability to ubiquitinate substrates. By controlling the proteasomal degradation of such substrates the NEDD8 pathway influences processes like cell cycle progression and signal transduction. Deregulation of this pathway can lead to alterations in cell proliferation and survival implicating it in numerous cellular mechanisms.
Pathways
NEDD8 and UBA3 are critical in the ubiquitin-proteasome system primarily through their involvement in the neddylation-modulated CRL pathway. This pathway controls the turnover of various proteins including those related to cell cycle control and apoptosis. The SCF (Skp Cullin F-box containing complex) ubiquitin ligase complex specifically associated with CRLs is one such critical entity involving NEDD8 establishing a link across multiple cellular pathways and functions. Interaction with the ubiquitin-like protein SUMO could also indicate a broader regulatory network within cellular machinery.
NEDD8 UBA3 activity has connections to cancer and neurodegenerative diseases. Abnormal neddylation often due to overactivation or inhibition can disrupt normal cell cycle progression and apoptosis contributing to oncogenesis. The overactive neddylation of mLNs such as through specific inhibitors like MLN4924 serves as a target for anti-cancer strategies. Furthermore studies have linked dysregulated neddylation processes to disorders such as Huntington's disease involving proteins like UCHL1 which also plays roles in protein stability and degradation.